Lineage Cell Therapeutics...

AMEX: LCTX · Real-Time Price · USD
0.85
0.04 (4.87%)
At close: Jun 16, 2025, 3:59 PM
0.89
4.75%
Pre-market: Jun 17, 2025, 04:31 AM EDT

Lineage Cell Therapeutics Revenue

Lineage Cell Therapeutics reported an annual revenue of $9.5M, reflecting a 6.19% growth. For the quarter ending March 31, 2025, Lineage Cell Therapeutics generated $1.5M in revenue.
Revenue (ttm)
$9.5M
Revenue Growth
6.19%
Price / Sales Ratio
10.59
Revenue / Employee
$135.7K
Employees
70
Market Cap
193.94M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.